Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Imagin Medical Inc C.IME

Alternate Symbol(s):  IMEXF

Imagin Medical Inc. is a urologic oncology company. It is engaged in developing technologies to better visualize and treat urologic cancers through minimally invasive surgery, including bladder and prostate cancer. Its first product, enCAGE Coil, is designed to eliminate the limitations of other methods of prostate cancer treatment that can cause erectile dysfunction and urinary incontinence. The device is a disposable, focal therapy, precision ablation system that will deliver bipolar, radio frequency energy through a distinctive coil electrode, or cage. It enables the surgeon to preset margins for precise tissue targeting. Its second product, the i/Blue Imaging System, will bring several key technological advancements that improve the utility of blue light imaging for visualizing bladder cancer. The i/Blue System delivers blue light imaging technology in a more versatile, practical, and accessible format and is designed to work with existing fiberoptic endoscopes on the market.


CSE:IME - Post by User

Bullboard Posts
Comment by KoolaidCash1on Jun 14, 2017 3:01pm
79 Views
Post# 26362794

RE:RE:Easar

RE:RE:Easar
radar17 wrote:
Why would you or anybody buy shares in this?  Its seems to have wound down to a comatose state. They had told investors just last December that they were going to start clinical trials in "early 2017".   Its now mid June 2017 and there has not been a peep about human trials.  I'm guessing they don't have any money left and have no real means of financing or raising more. 

To invest in something like this you should really have a reason other than "Hey, at least its cheap!!"


Yes a nickle for a bit. Financing not enough . Alumni not enough. To proceed without IRB. Rocky long 5 cent road. Just have to wait six months of lies comin our way. And another pp. Because no one will finance hand sitting. Period
Bullboard Posts